#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Plasma cell myeloma

Recruiting

Registered drugNo placebo

A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Metabolic dysfunction-associated liver disease

Recruiting

Investigational

N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Ly3437943 Sodium

Contact Research Centre

Gastrooesophageal cancer

Recruiting

Registered drugNo placebo

Evaluation of Safety and Efficacy of MK-2870 and Paclitaxel in Second-Line Treatment of Advanced/Metastatic Gastroesophageal Adenocarcinoma

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate

Contact Research Centre

Gastrointestinal cancer metastatic

Recruiting

InvestigationalNo placebo

Study of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Sunitinib

Contact Research Centre

Type IIa hyperlipidaemia

Recruiting

Investigational

A Study of Enlicitide for Safety and Effectiveness in Children and Adolescents with Heterozygous Familial Hypercholesterolemia

Investigational

Norway

Participants:0–17 years

Contact Research Centre

Osteochondrodysplasia

Recruiting

Investigational

A study testing the safety and effectiveness of infigratinib compared to placebo in infants and young children with achondroplasia

Investigational

Norway

Participants:0–17 years
Substances:Infigratinib

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

A study testing etentamig alone or with drug combinations in adult patients with multiple myeloma to assess safety and changes in disease activity

Registered drugNo placebo

Norway

Participants:18–64 years
Substances:Carfilzomib

Contact Research Centre

Short-bowel syndrome

Recruiting

Investigational

Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Glepaglutide

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Investigational

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:BLEXIMENIB

Contact Research Centre

Human papilloma virus immunisation

Recruiting

Registered drugNo placebo

A study on the long-term effectiveness and safety of nine-valent human papillomavirus vaccine in women aged 16 to 26 years for prevention of cervical cancer

Registered drugNo placebo

Norway

Participants:18–64 years · Healthy volunteers
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna

Contact Research Centre

Non-small cell lung cancer stage IIIA+2

Recruiting

Registered drugNo placebo

Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

B-cell type acute leukaemia

Recruiting

Registered drugNo placebo

Study of chemotherapy with blinatumomab and tyrosine kinase inhibitors in newly diagnosed children and young adults with Philadelphia chromosome positive B-cell acute lymphoblastic leukemia

Registered drugNo placebo

Norway

Participants:0–17 years · 18–64 years
Substances:Blinatumomab

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.